Rituxan ®

Generic Name: Rituximab

Drug Type:

Rituxan is a monoclonal antibody. (For more detail, see "How Rituxan Works" section below).

What Rituxan Is Used For:

Note: If a drug has been approved for one use, physicians sometimes elect to use this same drug for other problems if they believe it might be helpful.

How Rituxan Is Given:

Rituxan Side Effects:

Important things to remember about Rituxan side effects:

The following Rituxan side effects are common (occurring in greater than 30%) for patients taking Rituxan:

The following are less common Rituxan side effects (occurring in 10-29%) for patients receiving Rituxan:

A serious but rare Rituxan side effect is potential for a severe infusion reaction, typically with the first infusion (during infusion or within 30-120 minutes of infusion). You will be given medication prior to the infusion to decrease this reaction and monitored carefully during the infusion. If signs of reaction occur, the infusion is stopped. In most cases, the infusion can be restarted at a slower rate once symptoms subside.

Other rare but serious Rituxan side effects:

Not all Rituxan side effects are listed above. Some that are uncommon, occurring in less than 10% of patients, are not listed here. You should always inform your health care provider if you experience any unusual symptoms.

When To Contact Your Doctor or Health Care Provider:

Contact your health care provider immediately, day or night, if you should experience any of the following symptoms:

The following symptoms require medical attention, but are not emergency situations. Contact your health care provider within 24 hours of noticing any of the following:

Always inform your health care provider if you experience any unusual symptoms.

Rituxan Precautions:

Rituxan Self Care Tips:

Monitoring and Testing While Taking Rituxan:

You will be checked regularly by your health care provider while you are taking Rituxan, to monitor side effects and check your response to therapy. Periodic blood work to monitor your complete blood count (CBC) as well as the function of other organs (such as your kidneys and liver) may also be ordered by your doctor.

How Rituxan Works:

Rituxan is classified as a monoclonal antibody. Monoclonal antibodies are a relatively new type of "targeted" cancer therapy.

Antibodies are an integral part of the body's immune system. Normally, the body creates antibodies in response to an antigen (such as a protein in a germ) that has entered the body. The antibodies attach to the antigen in order to mark it for destruction by the immune system.

To make anti-cancer monoclonal antibodies in the laboratory, scientists analyze specific antigens on the surface of cancer cells (the targets). Then, using animal and human proteins, they create a specific antibody that will attach to the target antigen on the cancer cells. When given to the patient, these monoclonal antibodies will attach to matching antigens like a key fits a lock.

Since monoclonal antibodies target only specific cells, they may cause less toxicity to healthy cells. Monoclonal antibody therapy is usually given only for cancers in which antigens (and the respective antibodies) have been identified already.

Rituxan works by targeting the CD20 antigen on normal and malignant B-cells. Then the body's natural immune defenses are recruited to attack and kill the marked B-cells. Stem cells (young cells in the bone marrow that will develop into the various types of cells) do not have the CD20 antigen. This allows healthy B-cells to regenerate after treatment.

Note: We strongly encourage you to talk with your health care professional about your specific medical condition and treatments. The information contained in this website is meant to be helpful and educational, but is not a substitute for medical advice.